byetta glp-1 pharmaceuticals company overview Market Overview: Agonists and the Obesity Market | Blog GLP-1 Receptor Agonist Market Size
Description
A recently published, randomized, placebo-controlled trial found a greater reduction in BMI z-score (0.22 SDs) in adolescents receiving liraglutide compared with placebo
Berberine HCl supports metabolic health, aiding in fat burning, while Panax ginseng boosts energy to keep you active
Learn about the benefits and practical steps for transitioning patients from GLP-1 RAs to dual GLP-1/GIP receptor agonists, such as tirzepatide, to improve glycemic control in adults with type 2 diabetes.
Sandoz CEO Richard Saynor describes Canada as the world's second-largest GLP-1 market, raising cross-border supply concerns as generics near approval.
